Endocrine manifestations of craniopharyngioma

Child's Nervous System

Volumn 21, Issue 8-9, 2005, Pages 640-648

  Halac, Isil ^a   Zimmerman, Donald ^a,b  

^a CHILDREN'S MEMORIAL HOSPITAL   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Child; Craniopharyngioma surgery; Desmopressin administration and dosage; Growth hormone deficiency; Hypopituitarism drug therapy; Pituitary function tests; Pituitary neoplasms surgery; Postoperative complications drug therapy

Indexed keywords

CHORIONIC GONADOTROPIN; CONJUGATED ESTROGEN; CORTICOTROPIN; DESMOPRESSIN ACETATE; DEXAMPHETAMINE; EPITESTOSTERONE; ESTRADIOL; ESTROGEN; FOLLITROPIN; GLUCOCORTICOID; GONADOTROPIN; GROWTH HORMONE; HYDROCORTISONE; LEVOTHYROXINE; LEVOTHYROXINE SODIUM; LIOTHYRONINE; LUTEINIZING HORMONE; MEDROXYPROGESTERONE; MELATONIN; OCTREOTIDE; OXANDROLONE; PROLACTIN; RECOMBINANT FOLLITROPIN; RECOMBINANT LUTEINIZING HORMONE; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; TESTOSTERONE; TESTOSTERONE CIPIONATE; TESTOSTERONE ENANTATE; TESTOSTERONE PROPIONATE; THYROTROPIN; THYROXINE; VASOPRESSIN;

CHILD; CHILDHOOD MORTALITY; CLINICAL FEATURE; CORTICOTROPIN DEFICIENCY; CRANIOPHARYNGIOMA; DIABETES INSIPIDUS; ENDOCRINE DISEASE; GONADOTROPIN DEFICIENCY; GROWTH HORMONE DEFICIENCY; GROWTH RETARDATION; HORMONE DEFICIENCY; HORMONE DETERMINATION; HUMAN; HYPERPROLACTINEMIA; HYPOPHYSIS; HYPOTHALAMUS; HYPOTHYROIDISM; INAPPROPRIATE VASOPRESSIN SECRETION; LIVER TOXICITY; MORBIDITY; NEUROSURGERY; OBESITY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW;

ADRENOCORTICOTROPIC HORMONE; BODY WEIGHT; CHILD; CHILD, PRESCHOOL; CRANIOPHARYNGIOMA; ENDOCRINE SYSTEM; ENDOCRINE SYSTEM DISEASES; FOLLICLE STIMULATING HORMONE; HUMANS; LUTEINIZING HORMONE; NEUROPHYSINS; PITUITARY NEOPLASMS; POSTOPERATIVE COMPLICATIONS; PROTEIN PRECURSORS; THYROTROPIN; VASOPRESSINS;

EID: 24944440407     PISSN: 02567040     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00381-005-1246-x     Document Type: Review

References (48)

1. Chakrabarty A, Mitchell P, Bridges LR (1998) Craniopharyngioma invading the nasal and paranasal spaces, and presenting as nasal obstruction. Br J Neurosurg 12(4):361-363 10.1080/02688699844907
2. Sklar CA (1994) Craniopharyngioma: Endocrine abnormalities at presentation. Pediatr Neurosurg 21(Suppl 1):18-20 7841073
3. AG Robinson JG Verbalis 2003 Posterior pituitary gland In: PR Larsen HM Kronenberg S Melmed KS Polonsky (eds) Williams textbook of endocrinology Elsevier Science Philadelphia, PA 281-329
4. Banna M, Hoare RD, Stanley P, Till K (1973) Craniopharyngioma in children. J Pediatr 83(5):781-785 4742571
5. de Vries L, Lazar L, Phillip M (2003) Craniopharyngioma: Presentation and endocrine sequelae in 36 children. J Pediatr Endocrinol Metab 16(5):110-703 12880119
6. Thomsett MJ, Conte FA, Kaplan SL, Grumbach MM (1980) Endocrine and neurologic outcome in childhood craniopharyngioma: Review of effect of treatment in 42 patients. J Pediatr 97(5):728-735 7431164
7. Sorva R (1988) Children with craniopharyngioma. Early growth failure and rapid postoperative weight gain. Acta Paediatr Scand 77(4):587-592 3394513
8. Wit JM, Schuitema-Dijkstra A, van Buul-Offers S, Opmeer F, Van den Brande JL (1988) Excessive growth in a child with craniopharyngioma and growth hormone deficiency. Eur J Pediatr 147(6):658-661 10.1007/ BF00442487
9. Blethen SL, Weldon VV (1986) Outcome in children with normal growth following removal of a craniopharyngioma. Am J Med Sci 292(1):21-24 3717202
10. Weinzimer SA, Homan SA, Ferry RJ, Moshang T (1999) Serum IGF-I and IGFBP-3 concentrations do not accurately predict growth hormone deficiency in children with brain tumours. Clin Endocrinol (Oxf) 51(3):339-345 10.1046/j.1365-2265.1999.00804.x
11. Moshang T Jr, Rundle AC, Graves DA, Nickas J, Johanson A, Meadows A (1996) Brain tumor recurrence in children treated with growth hormone: the National Cooperative Growth Study experience. J Pediatr 128(5 Pt 2):S4-S7 8627468
12. Wilton P, Price DA (1992) Rate of relapse of craniopharyngioma in children treated with growth hormone. KIGS Biannu Rep No 8 1:48-54
13. Niu DM, Guo WY, Pan HC, Wong TT (2002) Rapid enlargement of a residual craniopharyngioma during short-term growth hormone replacement. Childs Nerv Syst 18(3-4):164-165. Epub 2002 Mar 5 10.1007/s00381-001-0552-1
14. Matson DD (1964) Craniopharyngioma. Clin Neurosurg 10:116-129 14095868
15. Lustig RH, Post SR, Srivannaboon K, Rose SR, Danish RK, Burghen GA, Xiong X, Wu S, Merchant TE (2003) Risk factors for the development of obesity in children surviving brain tumors. J Clin Endocrinol Metab 88(2):611-616 10.1210/jc.2002-021180
16. Muller HL, Emser A, Faldum A, Bruhnken G, Etavard-Gorris N, Gebhardt U, Oeverink R, Kolb R, Sorensen N (2004) Longitudinal study on growth and body mass index before and after diagnosis of childhood craniopharyngioma. J Clin Endocrinol Metab 89(7):3298-3305 10.1210/ jc.2003-031751
17. Attia N, Tamborlane WV, Heptulla R, Maggs D, Grozman A, Sherwin RS, Caprio S (1998) The metabolic syndrome and insulin-like growth factor I regulation in adolescent obesity. J Clin Endocrinol Metab 83(5):1467-1471 10.1210/jc.83.5.1467
18. Schoenle EJ, Zapf J, Prader A, Torresani T, Werder EA, Zachmann M (1995) Replacement of growth hormone (GH) in normally growing GH-deficient patients operated for craniopharyngioma. J Clin Endocrinol Metab 80(2):374-378 10.1210/jc.80.2.374
19. Pajas M, Lucas T, Garcia-Uria J, Salame F, Barcelo B, Estrada J (1995) Hypothalamic-pituitary dysfunction in patients with craniopharyngioma. Clin Endocrinol (Oxf) 42(5):467-473
20. Clopper RR, Mazur T, MacGillivray MH, Peterson RE, Voorhess ML (1983) Data on virilization and erotosexual behavior in male hypogonadotropic hypopituitarism during gonadotropin and androgen treatment. J Androl 4(5):303-311 6630049
21. Abbaticchio G, Micale FM, Giagulli VA, Giorgino R (1985) Recovery of fertility in a hypogonadotropic man apparently resistant to gonadotrophin treatment. Arch Androl 15(1):59-64 4096577
22. Volz J, Heinrich U, Volz-Koster S (2002) Conception and spontaneous delivery after total hypophysectomy. Fertil Steril 77(3):624-625 10.1016/ S0015-0282(01)03198-3
23. Hayashi M, Tomobe K, Hoshimoto K, Ohkura T (2002) Successful pregnancy following gonadotropin therapy in a patient with hypogonadotropic hypogonadism resulting from craniopharyngioma. Int J Clin Pract 56(2):149-151 11926704
24. Zachmann M, Illig R (1979) Precocious puberty after surgery for craniopharyngioma. J Pediatr 95(1):86-88 383931
25. Persani L, Ferretti E, Borgato S, Faglia G, Beck-Peccoz P (2000) Circulating thyrotropin bioactivity in sporadic central hypothyroidism. J Clin Endocrinol Metab 85(10):3631-3635 10.1210/jc.85.10.3631
26. Gruneiro-Papendieck L, Chiesa A, Martinez A, Heinrich JJ, Bergada C (1998) Nocturnal TSH surge and TRH test response in the evaluation of thyroid axis in hypothalamic pituitary disorders in childhood. Horm Res 50(5):252-257 10.1159/000023286
27. Bin-Abbas B, Mawlawi H, Sakati N, Khafaja Y, Chaudhary MA, Al-Ashwal A (2001) Endocrine sequelae of childhood craniopharyngioma. J Pediatr Endocrinol Metab 14(7):869-874 11515727
28. Isojarvi JI, Turkka J, Pakarinen AJ, Kotila M, Rattya J, Myllyla VV (2001) Thyroid function in men taking carbamazepine, oxcarbazepine, or valproate for epilepsy. Epilepsia 42(7):930-934 10.1046/ j.1528-1157.2001.042007930.x
29. Surks MI, DeFesi CR (1996) Normal serum free thyroid hormone concentrations in patients treated with phenytoin or carbamazepine. A paradox resolved. JAMA 275(19):1495-1498 10.1001/jama.275.19.1495
30. Lyen KR, Grant DB (1982) Endocrine function, morbidity, and mortality after surgery for craniopharyngioma. Arch Dis Child 57(11):837-841 6293388
31. Rose SR, Danish RK, Kearney NS, Schreiber RE, Lustig RH, Burghen GA, Hudson MM (2005) ACTH deficiency in childhood cancer survivors. Pediatr Blood Cancer, Feb 7
32. DM Styne GE Richards JJ Bell 1977 Growth patterns in congenital adrenal hyperplasia: Correlation of glucocorticoid therapy with stature In: P Lee L Plotnick A Kowarski C Migeon (eds) Congenital adrenal hyperplasia University Park Press Baltimore 247-261
33. Linder BL, Esteban NV, Yergey AL, Winterer JC, Loriaux DL, Cassorla F (1990) Cortisol production rate in childhood and adolescence. J Pediatr 117(6):892-896 2104527
34. Kerrigan JR, Veldhuis JD, Leyo SA, Iranmanesh A, Rogol AD (1993) Estimation of daily cortisol production and clearance rates in normal pubertal males by deconvolution analysis. J Clin Endocrinol Metab 76(6):1505-1510 10.1210/jc.76.6.1505
35. WL Miller 2003 The adrenal cortex In: MA Sperling (ed) Pediatric endocrinology Elsevier Science Philadelphia, PA 385-438
36. Lehrnbecher T, Muller-Scholden J, Danhauser-Leistner I, Sorensen N, von Stockhausen HB (1998) Perioperative fluid and electrolyte management in children undergoing surgery for craniopharyngioma. A 10-year experience in a single institution. Childs Nerv Syst 14(6):276-279 10.1007/ s003810050224
37. Gonzales-Portillo G, Tomita T (1998) The syndrome of inappropriate secretion of antidiuretic hormone: An unusual presentation for childhood craniopharyngioma: Report of three cases. Neurosurgery 42(4):917-921; discussion 921-922 10.1097/00006123-199804000-00131
38. Hetelekidis S, Barnes PD, Tao ML, Fischer EG, Schneider L, Scott RM, Tarbell NJ (1993) 20-year experience in childhood craniopharyngioma. Int J Radiat Oncol Biol Phys 27(2):189-195 8407391
39. Jeanrenaud B (1985) An hypothesis on the aetiology of obesity: dysfunction of the central nervous system as a primary cause. Diabetologia 28(8):502-513 Review 10.1007/BF00281984
40. Bray GA, York DA (1979) Hypothalamic and genetic obesity in experimental animals: An autonomic and endocrine hypothesis. Physiol Rev 59(3):719-809 379887
41. Smith DK, Sarfeh J, Howard L (1983) Truncal vagotomy in hypothalamic obesity. Lancet 1(8337):1330-1331 10.1016/S0140-6736(83)92437-6
42. Lustig RH, Rose SR, Burghen GA, Velasquez-Mieyer P, Broome DC, Smith K, Li H, Hudson MM, Heideman RL, Kun LE (1999) Hypothalamic obesity caused by cranial insult in children: Altered glucose and insulin dynamics and reversal by a somatostatin agonist. J Pediatr 135(2 Pt 1):162-168 10431109
43. Mason PW, Krawiecki N, Meacham LR (2002) The use of dextroamphetamine to treat obesity and hyperphagia in children treated for craniopharyngioma. Arch Pediatr Adolesc Med 156(9):887-892 12197795
44. Larijani B, Bastanhagh MH, Pajouhi M, Kargar Shadab F, Vasigh A, Aghakhani S (2004) Presentation and outcome of 93 cases of craniopharyngioma. Eur J Cancer Care (Engl) 13(1):11-15 10.1111/ j.1365-2354.2003.00433.x
45. Sorva R, Heiskanen O, Perheentupa J (1988) Craniopharyngioma surgery in children: Endocrine and visual outcome. Childs Nerv Syst 4(2):97-99 3401877
46. Nakasu Y, Nakasu S, Handa J, Takeuchi J (1980) Amenorrhea-galactorrhea syndrome with craniopharyngioma. Surg Neurol 13(2):154-156 6101923
47. Muller HL, Handwerker G, Wollny B, Faldum A, Sorensen N (2002) Melatonin secretion and increased daytime sleepiness in childhood craniopharyngioma patients. J Clin Endocrinol Metab 87(8):3993-3996 10.1210/jc.87.8.3993
48. Tomlinson JW, Holden N, Hills RK, Wheatley K, Clayton RN, Bates AS, Sheppard MC, Stewart PM (2001) Association between premature mortality and hypopituitarism. West midlands prospective hypopituitary study group. Lancet 357(9254):425-431 10.1016/S0140-6736(00)04006-X